The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)

Aim. To assess the influence of addition of nicorandil on long-term cardiovascular complications in patients with chronic coronary artery disease (CAD) in the framework of a prospective observational study.Material and methods. Prospective observational multicenter NIKEA study included 590 patients...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
Format: Article
Language:English
Published: Столичная издательская компания 2019-07-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1954
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227668014235648
author S. Yu. Martsevich
Yu. V. Lukina
N. P. Kutishenko
V. P. Voronina
N. A. Dmitrieva
A. V. Zagrebelnyy
O. V. Lerman
O. V. Gaisenok
T. A. Gomova
A. V. Ezhov
A. D. Kuimov
R. A. Libis
G. V. Matyushin
T. N. Mitroshina
G. I. Nechaeva
I. I. Reznik
V. V. Skibitsky
A. I. Chesnikova
N. V. Dobrynina
S. S. Yakushin
author_facet S. Yu. Martsevich
Yu. V. Lukina
N. P. Kutishenko
V. P. Voronina
N. A. Dmitrieva
A. V. Zagrebelnyy
O. V. Lerman
O. V. Gaisenok
T. A. Gomova
A. V. Ezhov
A. D. Kuimov
R. A. Libis
G. V. Matyushin
T. N. Mitroshina
G. I. Nechaeva
I. I. Reznik
V. V. Skibitsky
A. I. Chesnikova
N. V. Dobrynina
S. S. Yakushin
author_sort S. Yu. Martsevich
collection DOAJ
description Aim. To assess the influence of addition of nicorandil on long-term cardiovascular complications in patients with chronic coronary artery disease (CAD) in the framework of a prospective observational study.Material and methods. Prospective observational multicenter NIKEA study included 590 patients with stable CAD. All patients were recommended to add nicorandil to their baseline therapy. After 21 months, 547 telephone contacts were made, the life status of 524 people was specified, 23 patients were lost to follow-up. The following complications were registered: death from any cause; non-fatal myocardial infarction (MI); non-fatal stroke; urgent myocardial revascularization; hospitalization due to deterioration of CAD, chronic heart failure (CHF) or atrial fibrillation (AF). In 479 patients, a telephone survey was performed to identify adherence (persistence) to nicorandil– i.e. to verify the continuing the treatment for the prescribed duration.Results. During the follow-up period, 15 deaths were recorded, the causes of which were as follows: 3 CAD (2 MI, 1 left ventricular aneurysm), 1 pulmonary embolism, 2 CHF; 1 stroke, 1 oncology, 1 bilateral pneumonia. In the remaining 6 cases, the causes of death were not known. Cardiovascular (CV) complications were MI (8 cases in 7 patients, 1 patient had 2 MI in the follow-up period, 3 patients from this group died), stroke in 6 patients (7 cases, 1 patient had 2 strokes, 1 patient died). Urgent percutaneous coronary intervention was performed in 3 patients (in 2 patients due to acute MI, in 1 patient due to unstable angina). During the observation period, 21 people were urgently hospitalized due to deterioration of clinical condition. According to the results of a medical survey, by the end of the follow-up period, 237 people were not adherent to prescribed nicorandil, and 242 patients took the recommended medication (adherent patients). The main cardiovascular complications and death from any cause (р<0.001) as well as the number of urgent hospitalizations (р=0.017) were significantly more common in non-adherent to nicorandil patients in comparison with adherent patients.Conclusion. The overall rate of CAD complications in NIKEA study was typical for patients with stable CAD receiving contemporary medical therapy. Addition of nicorandil significantly reduced the rate of CV complications in adherent patients in comparison with non-adherent patients.
format Article
id doaj-art-95b4520d0f114768bf2f0b8f2b75417f
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2019-07-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-95b4520d0f114768bf2f0b8f2b75417f2025-08-23T10:00:31ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-07-0115333534210.20996/1819-6446-2019-15-3-335-3421613The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)S. Yu. Martsevich0Yu. V. Lukina1N. P. Kutishenko2V. P. Voronina3N. A. Dmitrieva4A. V. Zagrebelnyy5O. V. Lerman6O. V. Gaisenok7T. A. Gomova8A. V. Ezhov9A. D. Kuimov10R. A. Libis11G. V. Matyushin12T. N. Mitroshina13G. I. Nechaeva14I. I. Reznik15V. V. Skibitsky16A. I. Chesnikova17N. V. Dobrynina18S. S. Yakushin19National Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineJoint Hospital and Polyclinic, Administrative Department of the President of the Russian FederationTula Regional Clinical HospitalIzhevsk State Medical AcademyNovosibirsk State Medical UniversityOrenburg State Medical UniversityKrasnoyarsk State Medical University named after Prof. V.F. Voino-YasenetskyOut-patient Clinic №3Omsk State Medical UniversityUral State Medical UniversityKuban State Medical UniversityRostov State Medical UniversityRyazan State Medical University named after Academician I.P. PavlovRyazan State Medical University named after Academician I.P. PavlovAim. To assess the influence of addition of nicorandil on long-term cardiovascular complications in patients with chronic coronary artery disease (CAD) in the framework of a prospective observational study.Material and methods. Prospective observational multicenter NIKEA study included 590 patients with stable CAD. All patients were recommended to add nicorandil to their baseline therapy. After 21 months, 547 telephone contacts were made, the life status of 524 people was specified, 23 patients were lost to follow-up. The following complications were registered: death from any cause; non-fatal myocardial infarction (MI); non-fatal stroke; urgent myocardial revascularization; hospitalization due to deterioration of CAD, chronic heart failure (CHF) or atrial fibrillation (AF). In 479 patients, a telephone survey was performed to identify adherence (persistence) to nicorandil– i.e. to verify the continuing the treatment for the prescribed duration.Results. During the follow-up period, 15 deaths were recorded, the causes of which were as follows: 3 CAD (2 MI, 1 left ventricular aneurysm), 1 pulmonary embolism, 2 CHF; 1 stroke, 1 oncology, 1 bilateral pneumonia. In the remaining 6 cases, the causes of death were not known. Cardiovascular (CV) complications were MI (8 cases in 7 patients, 1 patient had 2 MI in the follow-up period, 3 patients from this group died), stroke in 6 patients (7 cases, 1 patient had 2 strokes, 1 patient died). Urgent percutaneous coronary intervention was performed in 3 patients (in 2 patients due to acute MI, in 1 patient due to unstable angina). During the observation period, 21 people were urgently hospitalized due to deterioration of clinical condition. According to the results of a medical survey, by the end of the follow-up period, 237 people were not adherent to prescribed nicorandil, and 242 patients took the recommended medication (adherent patients). The main cardiovascular complications and death from any cause (р<0.001) as well as the number of urgent hospitalizations (р=0.017) were significantly more common in non-adherent to nicorandil patients in comparison with adherent patients.Conclusion. The overall rate of CAD complications in NIKEA study was typical for patients with stable CAD receiving contemporary medical therapy. Addition of nicorandil significantly reduced the rate of CV complications in adherent patients in comparison with non-adherent patients.https://www.rpcardio.online/jour/article/view/1954observational studynicorandilstable angina pectoristreatment adherence
spellingShingle S. Yu. Martsevich
Yu. V. Lukina
N. P. Kutishenko
V. P. Voronina
N. A. Dmitrieva
A. V. Zagrebelnyy
O. V. Lerman
O. V. Gaisenok
T. A. Gomova
A. V. Ezhov
A. D. Kuimov
R. A. Libis
G. V. Matyushin
T. N. Mitroshina
G. I. Nechaeva
I. I. Reznik
V. V. Skibitsky
A. I. Chesnikova
N. V. Dobrynina
S. S. Yakushin
The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
Рациональная фармакотерапия в кардиологии
observational study
nicorandil
stable angina pectoris
treatment adherence
title The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
title_full The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
title_fullStr The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
title_full_unstemmed The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
title_short The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study)
title_sort first results of the evaluation of long term nicorandil treatment effect on the probability of cardiovascular complications in patients with stable coronary artery disease data of observational nikea study
topic observational study
nicorandil
stable angina pectoris
treatment adherence
url https://www.rpcardio.online/jour/article/view/1954
work_keys_str_mv AT syumartsevich thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT yuvlukina thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT npkutishenko thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT vpvoronina thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT nadmitrieva thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT avzagrebelnyy thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ovlerman thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ovgaisenok thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT tagomova thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT avezhov thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT adkuimov thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ralibis thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT gvmatyushin thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT tnmitroshina thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ginechaeva thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT iireznik thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT vvskibitsky thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT aichesnikova thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT nvdobrynina thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ssyakushin thefirstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT syumartsevich firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT yuvlukina firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT npkutishenko firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT vpvoronina firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT nadmitrieva firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT avzagrebelnyy firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ovlerman firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ovgaisenok firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT tagomova firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT avezhov firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT adkuimov firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ralibis firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT gvmatyushin firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT tnmitroshina firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ginechaeva firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT iireznik firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT vvskibitsky firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT aichesnikova firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT nvdobrynina firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy
AT ssyakushin firstresultsoftheevaluationoflongtermnicorandiltreatmenteffectontheprobabilityofcardiovascularcomplicationsinpatientswithstablecoronaryarterydiseasedataofobservationalnikeastudy